Mayo Clinic Health Manager
Get free personalized health guidance for you and your family.
Get StartedDefinition
By Mayo Clinic staffAge spots — also called liver spots and solar lentigines — are flat, gray, brown or black spots. They vary in size and usually appear on the face, hands, shoulders and arms — areas most exposed to the sun. Though age spots are very common in adults older than age 40, they can affect younger people as well.
True age spots are harmless and don't need treatment, but they can look like cancerous growths. For cosmetic reasons, age spots can be lightened with skin-bleaching products or removed. However, preventing age spots — by avoiding the sun and using sunscreen — may be the easiest way to maintain your skin's youthful appearance and to avoid these dark skin spots.
- Schaffer JV, et al. Benign pigmented skin lesions other than melanocytic nevi (moles). http://www.uptodate.com/home/index.html. Accessed Dec. 3, 2008.
- Ortonne JP, et al. Treatment of solar lentigines. Journal of the American Academy of Dermatology. 2006;54:S262.
- Farris PK. Combination therapy for solar lentigines. Journal of Drugs in Dermatology. 2004;3:S23.
- What you need to know about moles and dysplastic nevi. National Cancer Institute. http://www.cancer.gov/pdf/WYNTK/WYNTK_moles.pdf. Accessed Dec. 4, 2008.
- The sun and your skin. American Academy of Dermatology. http://www.aad.org/public/publications/pamphlets/sun_sun.html. Accessed Dec. 3, 2008.
- Habif TP. Light-related diseases and disorders of pigmentation. In: Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 4th ed. Philadelphia, Pa.: Mosby; 2004. http://www.mdconsult.com/das/book/body/112580021-4/0/1195/130.html?tocnode=51442208&fromURL=130.html#4-u1.0-B0-323-01319-8..50021-2--cesec13_2361. Accessed Dec. 4, 2008.
- Alpha hydroxy acids. Natural Medicines Comprehensive Database. http://www.naturaldatabase.com. Accessed Dec. 4, 2008.
- Draelos ZD. Skin lightening preparations and the hydroquinone controversy. Dermatologic Therapy. 2007;20:308.
- Chawla S, et al. Mechanism of tyrosinase inhibition by deoxyArbutin and its second-generation derivatives. British Journal of Dermatology. 2008;159:1267.